Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
clinical trials
deals
2
×
indiana blog main
indiana top stories
2
×
life sciences
national blog main
national top stories
san francisco blog main
2
×
san francisco top stories
wisconsin blog main
wisconsin top stories
abbvie
akouos
alexion pharmaceuticals
allergan
alnylam pharmaceutials
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
arrowhead pharmaceuticals
astrazeneca
biogen
bluerock therapeutics
boehringer ingelheim
boston
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
covid-19
crispr
deerfield management
detroit blog main
detroit top stories
dicerna pharmaceuticals
What
deal
medicines
2
×
abandoning
acquisitions
ago
announced
baggage
bio
ceo
collabs
companies
covid
cuts
daniel
development
dicerna
free
gets
gilead
gilead’s
help
interference
introduce
ipo
long
month
o’day
pharma
plans
rna
rnai
roundup
sciences
signs
small
transformative
wasn’t
years
Language
unset
Current search:
deals
×
medicines
×
" san francisco blog main "
×
biotech
×
" indiana top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
